Skip to main content

Table 1 HPV detection and type distribution in histologically confirmed ICC tissue samples from New Zealand women (N a = 227)

From: Type distribution of human papillomavirus among adult women diagnosed with invasive cervical cancer (stage 1b or higher) in New Zealand

Histological diagnosis/HPV type

All ICC types (N = 227)

ICC subtypes

ADC/ASC (N = 68)

SCC (N = 159)

 

nb

%c(95% CI)

n

% (95% CI)d

n

% (95% CI)

HPV positive

201

88.5 (83.7–92.4)

53

77.9 (66.2–87.1)

148

93.1 (88.0–96.5)

Any high-risk HPV

198

87.2 (82.2–91.3)

53

77.9 (66.2–87.1)

145

91.2 (85.7–95.1)

HPV-16

116

51.1 (44.4–57.8)

27

39.7 (28.0–52.3)

89

56.0 (47.9–63.8)

HPV-18

47

20.7 (15.6–26.6)

24

35.3 (24.1–47.8)

23

14.5 (9.4–20.9)

HPV-31

9

4.0 (1.8–7.4)

0

0.0 (0.0–5.3)

9

5.7 (2.6–10.5)

HPV-45

7

3.1 (1.2–6.3)

2

2.9 (0.4–10.2)

5

3.1 (1.0–7.2)

HPV-52

7

3.1 (1.2–6.3)

0

0.0 (0.0–5.3)

7

4.4 (1.8–8.9)

HPV-59

5

2.2 (0.7–5.1)

0

0.0 (0.0–5.3)

5

3.1 (1.0–7.2)

HPV-33

4

1.8 (0.5–4.5)

1

1.5 (0.0–7.9)

3

1.9 (0.4–5.4)

Other

17*

7.5 (4.4–11.7)

1

1.5 (0.0–7.9)

16

10.1 (5.9–15.8)

Any low-risk HPV

2

0.9 (0.1–3.1)

0

0.0 (0.0–5.3)

2

1.3 (0.2–4.5)

  1. anumber of women with the corresponding diagnosis.
  2. bnumber of women in each category.
  3. cpercentage of women in each category.
  4. dexact 95% confidence interval.
  5. ICC: Invasive cervical cancer; ADC: Adenocarcinoma; ASC: Adenosquamous carcinoma; SCC: Squamous cell carcinoma.
  6. *Includes 2 HPV types unidentifiable by LiPA.
  7. Other refers to HPV-35 (3 ICC samples), 39 (3), 51 (2), 56 (3), 66 (1), 68 (3) and –X (2 HPV types unidentifiable by LiPA).